OPHTHALMOLOGICAL COMPLICATIONS OF TYPE 2 DIABETES MELLITUS

DOI: https://doi.org/10.29296/25877305-2023-07-14
Issue: 
7
Year: 
2023

Associate Professor V. Churikov(1), Candidate of Medical Sciences; Associate Professor I. Lev(2), Candidate of Medical Sciences; Professor T. Yakunchenko(3), MD; V. Milyusin(4); M. Yastrebtsov(4); D. Osmina(4)
1-Voronezh State Medical University named after N.N. Burdenko
2-Tambov Branch, National Medical Research Center, Acad. S.N. Fyodorov
«Eye Microsurgery» Interdisciplinary Scientific and Technical Complex, Ministry of Health of Russia, Tambov
3-Belgorod State National Research University
4-Southwest State University, Kursk

The course and progression of type 2 diabetes mellitus (DM2) is often accompanied by the development of various ophthalmological complications, among which diabetic retinopathy (DR) is the most studied. However, other ophthalmological complications of DM2 in patients are presented in isolated publications and are not considered in dynamics. Objective. Investigation of the structure of ophthalmic complications of DM2 over a long time period. Subjects and methods. The study of ophthalmological complications of DM2 was carried out according to official medical statistics among the adult population of the Tambov region for 2016–2021. All complications of the organ of vision identified by ophthalmologists were analyzed by a retrospective method. For comparison, non-ophthalmological complications of DM2 were also considered. Results. Ophthalmological complications of DM2 among adults in the Tambov region amount to 22,9±2,5%, which is significantly lower than the proportion of neophthalmological complications of DM2 over the same period of time. The share of ophthalmic complications during the studied years significantly increased and, first of all, due to an increase in DR in the structure of complications from 11,5±2,1% in 2016 to 15,1±1,8% in 2021 (p
Keywords: 
endocrinology
type 2 diabetes mellitus
diabetic retinopathy
diabetic cataract
ophthalmological complications
adult population
screening.

References: 
  1. Avogaro A., Stehouwer C.D., Simo R. Diabetic retinopathy: looking beyond the eyes. Diabetologia. 2020; 63 (8): 1662–4. DOI: 10.1007/s00125-020-05195-4
  2. Yang J.H., Kwak H.W., Kim T.G. et al. Retinal Neurodegeneration in Type II Diabetic Otsuka Long-Evans Tokushima Fatty Rats. Investig Opthalmol Vis Sci. 2013; 54: 3844–51. DOI: 10.1167/iovs.12-11309
  3. Mathur R., Bhaskaran K., Edwards E. et al. Population trends in the 10-year incidence and prevalence of diabetic retinopathy in the UK: a cohort study in the Clinical Practice Research Datalink 2004–2014. BMJ Open. 2017; 7 (2): e014444. DOI: 10.1136/bmjopen-2016-014444
  4. Нероев В.В., Охоцимская Т.Д., Фадеева В.А. Оценка микрососудистых изменений сетчатки при сахарном диабете методом ОКТ-антиографии. Российский офтальмологический журнал. 2017; 10 (2): 40–5 [Neroev V.V., Okhotsimskaya T.D., Fadeeva V.A. Assessment of microvascular changes in the retina in diabetes mellitus by OCT-antiography. Russian Ophthalmological Journal. 2017; 10 (2): 40–5 (in Russ.)]. DOI: 10.18413/2658-6533-2021-7-4-0-10
  5. Wang J., Zhang R.Y., Chen R.P. et al. Prevalence and risk factors for diabetic retinopathy in a high-risk Chinese population. BMC Public Health. 2013; 13: 633. DOI: 10.1186/1471-2458-13-633
  6. Garoma D., Mega H., Hiko D. Determinants of diabetic retinopathy in Southwest Ethiopia: a facility-based case-control study. BMC Public Health. 2020; 20 (1): 503. DOI: 10.1186/s12889-020-08652-2
  7. Weerasekera L.Y., Balmer L.A., Ram R. et al. Characterization of Retinal Vascular and Neural Damage in a Novel Model of Diabetic Retinopathy. Invest Ophthalmol Vis Sci. 2015; 56 (6): 3721–30. DOI: 10.1167/iovs.14-16289
  8. Кирилюк М.Л., Ищенко В.А. Патогенез диабетической ретинопатии: обзор литературы. Международный эндокринологический журнал. 2019; 15 (7): 567–75 [Kirilyuk M.L., Ishchenko V.A. Pathogenesis of diabetic retinopathy: literature review. International Journal of Endocrinology. 2019; 15 (7): 567–75 (in Russ.)]. DOI: 10.22141/2224-0721.15.7.2019.186061
  9. Чупров А.Д., Лосицкий А.О., Фирсов А.С. Социально-экономические аспекты скрининга диабетической ретинопатии с использованием телемедицинских технологий. Современные технологии в офтальмологии. 2019; 2: 20–2 [Chuprov A.D., Lositsky A.O., Firsov A.S. Socio-economic aspects of diabetic retinopathy screening using telemedicine technologies. Modern technologies in ophthalmology. 2019; 2: 20–2 (in Russ.)]. DOI: 10.25276/2312-4911-2019-2-20-22
  10. Gulshan V., Rajan R.P., Widner K. et al. Performance of a Deep-Learning Algorithm vs Manual Grading for Detecting Diabetic Retinopathy in India. JAMA Ophthalmol. 2019; 137 (9): 987–93. DOI: 10.1001/jamaophthalmol.2019.2004
  11. Gubitosi-Klug R.A., Bebu I., White N.H. et al. Screening eye exams in youth with type 1 diabetes under 18 years of age: Once may be enough? Pediatr Diabetes. 2019; 20 (6): 743–9. DOI: 10.1111/pedi.12877
  12. Naik S., Wykoff C.C., Ou W.C. et al. Identification of factors to increase efficacy of telemedicine screening for diabetic retinopathy in endocrinology practices using the Intelligent Retinal Imaging System (IRIS) platform. Diabetes Res Clin Pract. 2018; 140: 265–70. DOI: 10.1016/j.diabres.2018.04.011
  13. Das T., Takkar B., Sivaprasad S. et al. Recently updated global diabetic retinopathy screening guidelines: commonalities, differences, and future possibilities. Eye (Lond). 2021; 35 (10): 2685–98. DOI: 10.1038/s41433-021-01572-4